Corvus Pharmaceuticals, Inc. (CRVS) Weighted Average Number of Shares Outstanding, Diluted 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
  • Corvus Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 49 M shares, a 5.33% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 48 M shares, a 3.16% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 46.6 M shares, a 11.2% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 41.9 M shares, a 42% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 48 M +1.47 M +3.16% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 46.6 M +4.7 M +11.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 41.9 M +12.4 M +42% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 29.5 M +129 K +0.44% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 29.3 M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.